CoChat

LSD-Assisted Psychotherapy in Patients with Terminal Cancer

Grof, S., Goodman, L.E., Richards, W.A., Kurland, A.A. · 2017 · International Pharmacopsychiatry

The DOI matches its Crossref record.

Abstract

The paper describes the results of a clinical study exploring the potential of a complex psychotherapeutic program utilizing psychedelic compounds to alleviate the emotional and physical suffering of cancer patients. A total of 60 cancer patients participated in this experimental study. In 44 of these patients, LSD (200-500 p%per os) was administered as an adjunct to psychotherapy; in 19 patients, a new psychedelic compound, dipropyltryptamine (DPT) was administered (60-105 mg i.m.). Three of these patients received both LSD and DPT administered on different sessions. The therapeutic results were assessed by means of a rating scale reflecting the degree of the patients’ depression, psychological isolation, anxiety, difficulty in management, fear of death, and pain. The ratings were done by attending physicians, nurses, family members, LSD therapists and cotherapists, and independent raters. In addition, the amount of narcotics required in the management of the patient was measured before and after the psychedelic sessions. Systematic rating was carried out in a group of 31 cancer patients treated by LSD. The comparison of the means of individual ratings from pre- to posttreatment showed significant improvement in all the measured parameters for most of the raters. There was a definite reduction of the narcotic medication; it did not, however, reach the level of statistical significance. The pre- to post-treatment comparison of the global indexes used as gross indicators of the degree of emotional and physical distress, indicated that approximately 29 % of the patients showed dramatic improvement, and another 41.9 % moderate improvement, with 22.6 % essentially unchanged. In 6.4 % of the patients, global indexes showed a decrement in the posttherapy ratings.

Overview

Integrity signals

Registry

Crossref · 10.1159/000467984

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 209

Metadata

Authors
Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A.
Venue
International Pharmacopsychiatry
Publisher
S. Karger AG
Published
2017-08-11
Volume
8
Issue
3
Pages
129-144
ISSN
  • 0020-8272 (ISSN-L)
  • 2504-2580
OpenAlex
W173089895
Cited by
209
References
0
Citations by year
2026: 17 · 2025: 18 · 2024: 22 · 2023: 22 · 2022: 19 · 2021: 15 · 2020: 13 · 2019: 9 · 2018: 10 · 2017: 4
FWCI
12.21
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • International Pharmacopsychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
  • Social Sciences › Health › Religion, Spirituality, and Psychology
Keywords
lysergic acid diethylamide, psychedelic therapy, terminal cancer, end-of-life care, depression, anxiety, psychological isolation, fear of death, pain management, emotional distress
MeSH terms
Adult, Aged, Anxiety, Attitude to Death, Clinical Trials as Topic, Depression, Female, Humans, Lysergic Acid Diethylamide, Male, Middle Aged, MMPI, Narcotics, Neoplasms, Palliative Care, Psychiatric Status Rating Scales, Psychotherapy, Terminal Care, Tryptamines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LSD-Assisted Psychotherapy in Patients with Terminal Cancer. https://app.cochat.ai/papers/10.1159/000467984
The paper
Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. (2017). LSD-Assisted Psychotherapy in Patients with Terminal Cancer. International Pharmacopsychiatry. https://doi.org/10.1159/000467984

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.